Arphra/Issuer/PHAR

PHAR

Pharming Group N.V.

HealthcareBiotechnologyNLUSDCountry macro →

$12.99

LiveMay 29, 2026

AI Brief

Market cap

$917.42M

52w range

9.54 – 21.34

P / E

—

EPS

—

Volume

21.76K

Revenue · FY

—

Explain this page

Arphra AIPlain-English read on Pharming Group N.V.’s valuation

AI Issuer Brief

Arphra AI

Loading cached brief…

Insider · 30d

Bought

0 txns

Sold

0 txns

Net flow

+$0

Full history →

Price

DB · prices_daily

1M 6M 1Y 5Y

No price history in prices_daily for PHAR.

Peers

No peer list available for PHAR.

Price change · trailing returns

Live

1D	5D	1M	3M	6M	YTD	1Y	3Y	5Y	10Y	Max
-4.90%	-3.28%	-23.50%	-20.31%	-19.96%	-26.49%	+15.57%	+7.00%	+5.76%	-22.22%	-22.22%

Aftermarket

Live

Jun 01, 08:00 AM

Last trade

$13.41

1 sh

Bid

$13.02

12,100 sh

Ask

$16.53

100 sh

Spread

$3.510

Sector & industry today

Live

Sectors

Technology
+0.21%
Basic Materials
+0.15%
Financial Services
-0.43%
Industrials
-0.48%
Energy
-0.58%
Consumer Defensive
-0.79%
Consumer Cyclical
-0.85%
Real Estate
-0.98%
Healthcare
-1.37%
Communication Services
-1.47%
Utilities
-2.07%

Top industries (issuer's industry highlighted)

Biotechnology
+0.06%
Software - Infrastructure
+6.80%
Coal
-6.27%
Information Technology Services
+6.00%
Medical - Healthcare Information Services
+5.23%
Other Precious Metals
+3.84%
Broadcasting
-3.48%
Silver
+2.89%
Renewable Utilities
-2.75%
Software - Application
+2.71%
Travel Lodging
-2.70%
Internet Content & Information
-2.61%

Fair value

Football field →

Weighted blend

—

— vs spot

Recommendation

n/a

0 of 0 methods

Method spread

0bull0bear

±5% threshold

Analyst PT consensus: $38.00 (+192.53%)

Total assets

—

Total debt

—

Cash & equiv

—

Operating CF

—

Free cash flow

—

Buybacks

—

Analyst view

Consensus target

—

No price-target data returned for this ticker.

Recent actions

0 ↑0 ↓0 hold

No recent grade actions.

News

DB · news_items

Pharming Group Q1 Earnings Call Highlights
marketbeat.com·May 08, 2026

Recent quarters

All financials →

Period	Revenue	Net income	EPS

Recent insiders

All →

Insider	Action	Shares	Value	Date
No open-market insider activity in the recent window.

Income statement · annual

Open Financials →

Period	Revenue	Op income	Net income	EPS	Net margin